TYVASO DPI IS NOW APPROVED

Learn more
Skip to main content
SELECT A CONDITION
PATIENT SUPPORT PROGRAM
SELECT A CONDITION
PATIENT SUPPORT PROGRAM

HOW TO
TAKE TYVASO

Taking TYVASO

TYVASO is a medication you inhale directly to your lungs. TYVASO is inhaled during 4 short treatment sessions each day.

TYVASO DPI device

TYVASO DPI (treprostinil) Inhalation Powder

TYVASO Nebulizer device

TYVASO (treprostinil) Inhalation Solution

Portability

Small, portable dry powder inhaler that fits in the palm of your hand

Handheld nebulizer that can be charged overnight for cordless flexibility

Setup

Insert single-dose cartridge and take a breath. Replace inhaler every 7 days

Set up device 1x each morning, clean device 1x each night

Dosing

4x daily
Each dose is inhaled in less than 2 seconds

4x daily
Each session takes about 2-3 minutes

Titration

Most people start with a 16 mcg cartridge and take 1 breath per cartridge, 4x daily. The dose is then typically increased to the next cartridge strength every 1-2 weeks* until they reach a target maintenance dose of 48 to 64 mcg, taken with 1 breath per cartridge, 4x daily

Learn about reaching target maintenance dose

Most people start with 3 breaths, 4x daily, and increase by 3 breaths per session every week to a target maintenance dose of 9-12 breaths, 4x daily

Learn about reaching target maintenance dose
TYVASO DPI device

TYVASO DPI (treprostinil) Inhalation Powder

Portability

Small, portable dry powder inhaler that fits in the palm of your hand

Setup

Insert single-dose cartridge and take a breath. Replace inhaler every 7 days

Dosing

4x daily
Each dose is inhaled in less than 2 seconds

Titration

Most people start with a 16 mcg cartridge and take 1 breath per cartridge, 4x daily. The dose is then typically increased to the next cartridge strength every 1-2 weeks* until they reach a target maintenance dose of 48 to 64 mcg, taken with 1 breath per cartridge, 4x daily

Learn about reaching target maintenance dose
TYVASO Nebulizer device

TYVASO (treprostinil) Inhalation Solution

Portability

Handheld nebulizer that can be charged overnight for cordless flexibility

Setup

Set up device 1x each morning, clean device 1x each night

Dosing

4x daily
Each session takes about 2-3 minutes

Titration

Most people start with 3 breaths, 4x daily, and increase by 3 breaths per session every week to a target maintenance dose of 9-12 breaths, 4x daily

Learn about reaching target maintenance dose

Your doctor will work with you to reach your target maintenance dose, which is important so that you’ll get the full benefit of your medicine. Titration schedules may vary based on how you tolerate the medicine.

If the prescribed dose is higher than 64 mcg per treatment session, more than 1 cartridge will be needed per session.

HOW TO USE TYVASO DPI

TYVASO DPI is another device option for your TYVASO treatment.

DOWNLOAD TYVASO DPI INSTRUCTIONS FOR USE

Dosing with TYVASO DPI and Getting to Your Target Maintenance Dose

Your doctor will work with you to increase your dose until you reach your target maintenance dose. This process is called “titration.”

Most people start with the 16 mcg cartridge, 4x daily, and increase their dose every 1-2 weeks until they reach their target maintenance dose.

HOW TO USE THE TYVASO NEBULIZER

TYVASO is delivered through a portable nebulizer.

DOWNLOAD TYVASO NEBULIZER INSTRUCTIONS FOR USE

Dosing with the TYVASO Nebulizer and Getting to Your Target Maintenance Dose

Your doctor will work with you to increase the number of breaths per session each week until you reach the target maintenance dose. It took patients in the clinical study an average of 3 weeks to reach their target dose.

TYVASO Nebulizer Treatment Tracker

Your personal diary for keeping track of your treatment sessions. See how TYVASO fits into your daily life.

DOWNLOAD TREATMENT TRACKER

You May Have Side Effects

Talk to your healthcare provider and click below to learn more about potential side effects.

WHAT SHOULD I KNOW?

bubbles for design
quotes icon
It fits into my lifestyle. I’m able to do my day-to-day activities.

– TYVASO Patient
Individual results may vary.

IMPORTANT SAFETY
INFORMATION

Before you take TYVASO or TYVASO DPI, tell your healthcare provider about all of your medical conditions, including if you:

  • Have low blood pressure
  • Have or have had bleeding problems
EXPAND

IMPORTANT SAFETY
INFORMATION

COLLAPSE

Before you take TYVASO or TYVASO DPI, tell your healthcare provider about all of your medical conditions, including if you:

  • Have low blood pressure
  • Have or have had bleeding problems
  • Have asthma or chronic obstructive pulmonary disease (COPD)
  • Are pregnant or plan to become pregnant. It is not known if either product will harm your unborn baby.
  • Are breastfeeding or plan to breastfeed. It is not known if either product passes into your breast milk. Talk to your healthcare provider about the best way to feed your baby during treatment.

Tell your healthcare provider about all of the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Either product and other medicines may affect each other.

Especially tell your healthcare provider if you take:

  • Medicines used to treat high blood pressure or heart disease
  • Medicines that decrease blood clotting (anticoagulants)
  • Water pills (diuretics)
  • Gemfibrozil (Lopid®) or rifampin (Rimactane®, Rifadin®, Rifamate®, Rifater®)

What are the possible side effects of TYVASO or TYVASO DPI?

Both products can cause serious side effects, including:

  • Low blood pressure (symptomatic hypotension). If you have low blood pressure, either product may lower your blood pressure more.
  • Bleeding problems. Either product may increase the risk of bleeding, especially in people who take blood thinners (anticoagulants).

The most common side effects of both products are cough, headache, throat irritation and pain, nausea, reddening of the face and neck (flushing), fainting or loss of consciousness, dizziness, diarrhea, and shortness of breath. Like other inhaled prostaglandins, you may have trouble breathing after taking TYVASO or TYVASO DPI because it may cause the muscles around your airway to tighten (bronchospasm). These are not all the possible side effects. Call your doctor for medical advice about side effects or if you have trouble breathing.

You may report side effects to the FDA at 

You are now leaving the Tyvaso.com website

This link will take you to a site maintained by a third party who is solely responsible for the site’s content. Click CONTINUE to proceed or CLOSE to return to www.TYVASO.com.

CONTINUE
www.fda.gov/MedWatch

or call 1-800-FDA-1088.

What are TYVASO and TYVASO DPI?

TYVASO (treprostinil) Inhalation Solution and TYVASO DPI (treprostinil) Inhalation Powder are prescription medicines used in adults to treat:

  • Pulmonary arterial hypertension (PAH; WHO Group 1), which is high blood pressure in the arteries of your lungs. TYVASO or TYVASO DPI can improve the ability to exercise. Your ability to exercise decreases 4 hours after taking TYVASO or TYVASO DPI. It is not known if TYVASO or TYVASO DPI is safe and effective in children under 18 years of age.
  • Pulmonary hypertension associated with interstitial lung disease (PH-ILD; WHO Group 3), which is high blood pressure in the lungs due to inflammation and sometimes scarring in the lungs. TYVASO or TYVASO DPI can improve the ability to exercise.

The risk information provided here is not comprehensive. To learn more about TYVASO or TYVASO DPI, talk with your healthcare provider. Please see Full Prescribing Information for TYVASO or TYVASO DPI, Instructions for Use manuals for TD-100 and TD-300 TYVASO® Inhalation System and TYVASO DPI™ Inhalation Powder, and additional information at www.TYVASO.com or call 1-877-UNITHER (1-877-864-8437).


TYVISIconMAY2022

DPI=dry powder inhaler.

Drug Discard Program Privacy Policy Terms of Use Contact Us Site Map

TYVASO and TYVASO DPI are registered trademarks of United Therapeutics Corporation.

All other brands are trademarks of their respective owners. The makers of these brands are not affiliated with and do not endorse United Therapeutics or its products.

© 2023 United Therapeutics Corporation. All rights reserved. US/TYV/0798